Thursday, November 03, 2011

GSK to Pay $3B to Settle US Govt. Probes - Nov. 3, 2011

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Thursday, November 03, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Pharm-Olam International Acquires StatWorks, Inc.

With Pharm-Olam's acquisition of StatWorks we have expanded our team Data Management and Biostatistics experts for functional outsourcing and full service clinical trials. Our comprehensive biometric services include:

• Integration of randomization into EDC systems, eliminating IVRS costs, with added benefit of full inventory control over supplies
• Adaptive, Sequential, and Bayesian design methods
• CDISC, SDTM and ADaM datasets
• SAS programming, eCRF design, and medical coding in MedDRA/WHO Drug
• Streamlining and reconciling across SAE, CTMS, and study DB
• Health Outcomes Research and Patient Reported Outcomes
• Protocol development, sample size, and randomization

Contact us for your resource planning atwww.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
HeadHtml
•   GlaxoSmithKline (GSK) to Pay $3 Billion to Settle US Government Probes More...
More Legal News
HeadHtml
•  Verastem, Inc. Braves the Public Market, Files for $50 Million IPO More...
More IPO News
More IPO Filing News
More IPO Withdraw
More IPO Updates
HeadHtml
•   NanoViricides, Inc. (NNVC.PK) Raises an Additional $5 Million in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand More...
More Finance News
Featured Free Resource

Bioscience Technology

This magazine provides information to life science/biotech researchers searching for technology, tools and techniques to conduct better, more cost-efficient and effective research.

Request Now!
HeadHtml
•   Novo Nordisk A/S (NVO) Rejects China M&A; Plans Growth Through Innovation More...
•   Innophos Holdings, Inc. Announces Acquisition of Kelatron Corporation for $21 Million More...
•   Ipsen Sells the North American1 Development and Marketing Rights for Apokyn® to Britannia Pharmaceuticals Limited, Achieving a Key Milestone in the Execution of its New North American Strategy More...
•   Synageva BioPharma Announces Completion of Merger with Trimeris, Inc. (TRMS) More...
More Mergers and Acquisitions News
HeadHtml
•   GlaxoSmithKline (GSK), Pfizer Inc. (PFE) HIV Venture Plans Russian Manufacturing More...
•   Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development More...
•   ImmunoGen, Inc. (IMGN) Earns Milestone From Amgen (AMGN) With IND Achievement More...
•   IsoRay, Inc. (ISR) Announces Major International Distribution Agreement for GliaSite® More...
•   ASLAN Pharmaceuticals Pte Ltd and Bristol-Myers Squibb Company (BMY) Enter Innovative Partnership to License and Develop Investigational Oncology Compound More...
More Alliances News

•   CollabRx Launches New Lung Cancer Clinical Decision Support Tool for Patients and Oncologists, Appoints New CEO More...
•   Viamet Pharmaceuticals Appoints Former Novartis Corporation (NVS) Executive Marc Rudoltz, M.D. as Chief Medical Officer More...
•   Virobay Appoints David B. Karpf, M.D. as Chief Medicial Officer More...
More Personnel News
Tower: Facebook
HeadHtml
•   Agennix AG Reports Financial Results for Third Quarter and First Nine Months of 2011 More...
•   Active Biotech AB (BTPC) Interim Report January - September 2011 More...
•   Allos Therapeutics, Inc. (ALTH) Reports Third Quarter 2011 Financial Results More...
•   Ariad Pharmaceuticals, Inc. (ARIA) Reports Third Quarter 2011 Financial Results and Development Progress More...
•   ArQule, Inc. (ARQL) to Report Third Quarter 2011 Financial Results on November 10, 2011 More...
More Earnings Report News
Real Estate



R&D/Laboratory Facility For Sublease
7 Graphics Drive
Ewing, New Jersey U.S.A.

Building Size: 72,300 SF
Available Area: 18,577 RSF
Rental Rate: Negotiable

More Real Estate Listings
Feature

Hot Company

Aptalis Pharmaceutical Technologies
100 Somerset Corporate Boulevard, Suite 2000
Bridgewater, New Jersey 08807 U.S.A.
Phone: 908-429-4479, Ext. 4085

The Aptalis Pharmaceutical Technologies (formerly Eurand Pharmaceutical Technologies) business specializes in product development that leverages our proprietary pharmaceutical technologies. We utilize these technologies to develop novel prescription and OTC products with our partners that are designed to have advantages over existing products and address unmet medical needs.

More Company Profiles
Events

Acceleration 2011: Nutter Early Stage Life Sciences Conference
Thursday, November 17, 2011
Nutter Conference Center, Seaport West 155 Seaport Boulevard, 5th Floor
Boston, Massachusetts

This free event is by invitation only. To request an invitation, please visit: www.acceleration.nutter.com/2011.

An outstanding line-up of speakers is being assembled for this conference including representatives of Atlas Venture, GlaxoSmithKline (GSK), Novartis, Smith and Nephew, Longwood Founders Fund, and Pfizer.

Two panel discussions will examine issues and trends in early-stage development among life science companies.

Panel I will seek to answer the question "How Lean is Too Lean?" and will consider some of the pitfalls and challenges faced by development stage life science companies as they execute on a lean business model from raw technology through the clinical and operational phases of development and finally to commercial launch.

Panel II asks "Are Big Pharma and Big Device the New Development Accelerators?" and will examine how large companies are deploying new external investment and development models to optimize their "buy" and "build" pipelines. The program will be followed by cocktails, hors d'oeuvres and networking

To request an invitation, please visit www.acceleration.nutter.com/2011.
 
Top Jobs
BioMidwest (Chicago, Illinois)

MicroPhage, Inc.
Territory Sales Manager
Responsible for achieving sales goals through a coordinated effort with a distribution network in their assigned territory. Educates, trains and leads distributor sales managers and representatives to effectively launch and rapidly penetrate the market. Along with distributor partners, initiates and leads the integrated health system sales process including demand development, evaluation, and decision-making process.

Pharm Country (Basking Ridge, New Jersey)

Ipsen
Director, Sales Operations
Develop and manage policies and procedures and be responsible for the implementation of them, e.g., compliance related activities. Key stakeholders will include organizational leaders within the field force organization, In addition to analyzing the trends, efficiencies, and effectiveness of the sales force.

BioCapital (Baltimore, Maryland)

Astellas Pharma US
Regional Sales Manager, Hospital
Responsible for the development of sales strategies and achievement of Primary Care sales objectives within a determined geography. This position is also responsible for the management and development of 8-12 Professional Representatives (PCPs), market activities, and company resources within a given district that are directed specifically at maximizing territory, district, area and national sales goals and market share objectives.

Rocky Bio (Longmont, Colorado)

MicroPhage, Inc.
Territory Sales Manager
Responsible for achieving sales goals through a coordinated effort with a distribution network in their assigned territory. Educates, trains and leads distributor sales managers and representatives to effectively launch and rapidly penetrate the market. Along with distributor partners, initiates and leads the integrated health system sales process including demand development, evaluation, and decision-making process.

Genetown (Cambridge, Massachusetts)

Pfizer, Inc.
Manager, Business Innovations and Strategy
The primary focus of the role is to develop a strategic understanding of the commercial environment to inform the research and clinical strategy in order to ensure full alignment between the research and business unit organizations.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs

Genetown Career Fair

Genetown Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


No comments: